These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 952578)

  • 21. [The pharmacokinetics of 14C-zolimidine in rats].
    Schraven E; Trottnow D
    Arzneimittelforschung; 1976 Feb; 26(2):213-8. PubMed ID: 947201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat.
    Ehrström M; Näslund E; Levin F; Kaur R; Kirchgessner AL; Theodorsson E; Hellström PM
    Regul Pept; 2004 Jul; 119(3):209-12. PubMed ID: 15120482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenously administered meptazinol during general anaesthesia in man.
    Gepts E; Sonck WA; Camu F; Vercruysse A
    Eur J Anaesthesiol; 1987 Jan; 4(1):35-43. PubMed ID: 3582376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat.
    De Paepe P; Belpaire FM; Van Hoey G; Boon PA; Buylaert WA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1048-53. PubMed ID: 10454477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of terbutaline after subcutaneous administration.
    Leferink JG; Lamont H; Wagemaker-Engels I; Maes RA; Pouwels R; van der Straeten M
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):181-5. PubMed ID: 447439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of alpha-dihydroergocryptine in rats after intravenous and oral administration.
    Grognet JM; Istin M; Zanotti A; Mailland F; Coppi G
    Arzneimittelforschung; 1991 Jul; 41(7):689-91. PubMed ID: 1772454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Michaelis-Menten elimination kinetics of acetate in rabbit.
    Fujimiya T; Li YJ; Uemura K; Ohbora Y
    Alcohol Clin Exp Res; 1999 Sep; 23(9):1452-6. PubMed ID: 10512309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
    Somani SM; Khalique A
    Drug Metab Dispos; 1987; 15(5):627-33. PubMed ID: 2891478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane).
    Houghton GW; Dennis MJ; Templeton R; Martin BK
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):97-100. PubMed ID: 3988401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
    Rivière GJ; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of alfentanil in man.
    Camu F; Gepts E; Rucquoi M; Heykants J
    Anesth Analg; 1982 Aug; 61(8):657-61. PubMed ID: 6124179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Compartment simulation models and physiologic use in pharmaco- and toxicokinetics].
    Kostrzewski P
    Med Pr; 1998; 49(1):83-92. PubMed ID: 9587914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etomidate, a new short acting, intravenous hypnotic.
    Zindler M
    Acta Anaesthesiol Belg; 1976; 27 suppl():143-52. PubMed ID: 1015214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.
    Husain SS; Pejo E; Ge R; Raines DE
    Anesthesiology; 2012 Nov; 117(5):1027-36. PubMed ID: 22929736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
    Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
    Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics of etomidate].
    Levron JC; Assoune P
    Ann Fr Anesth Reanim; 1990; 9(2):123-6. PubMed ID: 2363548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of etomidate, a new intravenous anesthetic.
    Van Hamme MJ; Ghoneim MM; Ambre JJ
    Anesthesiology; 1978 Oct; 49(4):274-7. PubMed ID: 697083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease.
    Su F; El-Komy MH; Hammer GB; Frymoyer A; Cohane CA; Drover DR
    Biopharm Drug Dispos; 2015 Mar; 36(2):104-14. PubMed ID: 25377074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Hypnotic Recoveries After Infusions of Methoxycarbonyl Etomidate and Cyclopropyl Methoxycarbonyl Metomidate: The Role of the Metabolite.
    Pejo E; Liu J; Lin X; Raines DE
    Anesth Analg; 2016 Apr; 122(4):1008-14. PubMed ID: 26991617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.